SELVITA S A has a total of 46 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BOEHRINGER INGELHEIM LTD, GUILLEMONT JEROME EMILE GEORGES and CERMOL SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | United States | 6 | |
#4 | Canada | 5 | |
#5 | China | 3 | |
#6 | Argentina | 2 | |
#7 | Australia | 2 | |
#8 | Brazil | 2 | |
#9 | Hungary | 2 | |
#10 | Israel | 2 | |
#11 | Mexico | 2 | |
#12 | Serbia | 2 | |
#13 | Taiwan | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Galezowski Michal | 23 |
#2 | Rzymski Tomasz | 17 |
#3 | Milik Mariusz | 15 |
#4 | Czardybon Wojciech | 15 |
#5 | Nowak Mateusz Oktawian | 11 |
#6 | Guzik Pawel Szczepan | 11 |
#7 | Sabiniarz Aleksandra Barbara | 11 |
#8 | Wiklik Katarzyna | 11 |
#9 | Horvath Raymond | 11 |
#10 | Brzozka Krzysztof | 11 |
Publication | Filing date | Title |
---|---|---|
US2018265467A1 | Pyrazolidine derivatives and related compounds | |
EP3294728A1 | Substituted quinoxaline derivatives | |
CA2979302A1 | Substituted quinoxaline derivatives | |
US2016009697A1 | Pyridine derivatives as 5-ht6 receptor antagonists | |
EP2499117A1 | A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent | |
EP2366695A1 | A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent | |
US2011112091A1 | Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a method of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |